Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA vs UDCA in Primary Biliary Cholangitis
NCT01829698Phase 3Completed
- Sponsor
- Beijing Trendful Kangjian Medical Information Consulting Co., Ltd.
- Start
- Aug 2009
- Primary completion
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tauroursodeoxycholic acid in primary biliary cholangitis (PBC), sponsored by Beijing Trendful Kangjian Medical Information Consulting Co., Ltd.. Started Aug 2009; status: completed.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT01829698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01829698.